225 related articles for article (PubMed ID: 23155374)
1. Antibody to Epstein-Barr virus deoxyuridine triphosphate nucleotidohydrolase and deoxyribonucleotide polymerase in a chronic fatigue syndrome subset.
Lerner AM; Ariza ME; Williams M; Jason L; Beqaj S; Fitzgerald JT; Lemeshow S; Glaser R
PLoS One; 2012; 7(11):e47891. PubMed ID: 23155374
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr Virus dUTPase Induces Neuroinflammatory Mediators: Implications for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
Williams PhD MV; Cox B; Lafuse PhD WP; Ariza ME
Clin Ther; 2019 May; 41(5):848-863. PubMed ID: 31040055
[TBL] [Abstract][Full Text] [Related]
3. IgM serum antibodies to Epstein-Barr virus are uniquely present in a subset of patients with the chronic fatigue syndrome.
Lerner AM; Beqaj SH; Deeter RG; Fitzgerald JT
In Vivo; 2004; 18(2):101-6. PubMed ID: 15113035
[TBL] [Abstract][Full Text] [Related]
4. Myalgic encephalomyelitis/chronic fatigue syndrome and gulf war illness patients exhibit increased humoral responses to the herpesviruses-encoded dUTPase: Implications in disease pathophysiology.
Halpin P; Williams MV; Klimas NG; Fletcher MA; Barnes Z; Ariza ME
J Med Virol; 2017 Sep; 89(9):1636-1645. PubMed ID: 28303641
[TBL] [Abstract][Full Text] [Related]
5. A six-month trial of valacyclovir in the Epstein-Barr virus subset of chronic fatigue syndrome: improvement in left ventricular function.
Lerner AM; Beqaj SH; Deeter RG; Dworkin HJ; Zervos M; Chang CH; Fitzgerald JT; Goldstein J; O'Neill W
Drugs Today (Barc); 2002 Aug; 38(8):549-61. PubMed ID: 12582420
[TBL] [Abstract][Full Text] [Related]
6. Serological and virological investigation of the role of the herpesviruses EBV, CMV and HHV-6 in post-infective fatigue syndrome.
Cameron B; Flamand L; Juwana H; Middeldorp J; Naing Z; Rawlinson W; Ablashi D; Lloyd A
J Med Virol; 2010 Oct; 82(10):1684-8. PubMed ID: 20827765
[TBL] [Abstract][Full Text] [Related]
7. Valacyclovir treatment in Epstein-Barr virus subset chronic fatigue syndrome: thirty-six months follow-up.
Lerner AM; Beqaj SH; Deeter RG; Fitzgerald JT
In Vivo; 2007; 21(5):707-13. PubMed ID: 18019402
[TBL] [Abstract][Full Text] [Related]
8. Response to valganciclovir in chronic fatigue syndrome patients with human herpesvirus 6 and Epstein-Barr virus IgG antibody titers.
Watt T; Oberfoell S; Balise R; Lunn MR; Kar AK; Merrihew L; Bhangoo MS; Montoya JG
J Med Virol; 2012 Dec; 84(12):1967-74. PubMed ID: 23080504
[TBL] [Abstract][Full Text] [Related]
9. Antibodies to Epstein-Barr virus-specific DNase and DNA polymerase in the chronic fatigue syndrome.
Jones JF; Williams M; Schooley RT; Robinson C; Glaser R
Arch Intern Med; 1988 Sep; 148(9):1957-60. PubMed ID: 2843138
[TBL] [Abstract][Full Text] [Related]
10. Deficient EBV-specific B- and T-cell response in patients with chronic fatigue syndrome.
Loebel M; Strohschein K; Giannini C; Koelsch U; Bauer S; Doebis C; Thomas S; Unterwalder N; von Baehr V; Reinke P; Knops M; Hanitsch LG; Meisel C; Volk HD; Scheibenbogen C
PLoS One; 2014; 9(1):e85387. PubMed ID: 24454857
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of abnormal cardiac wall motion in the cardiomyopathy associated with incomplete multiplication of Epstein-barr Virus and/or cytomegalovirus in patients with chronic fatigue syndrome.
Lerner AM; Dworkin HJ; Sayyed T; Chang CH; Fitzgerald JT; Beqaj S; Deeter RG; Goldstein J; Gottipolu P; O'Neill W
In Vivo; 2004; 18(4):417-24. PubMed ID: 15369178
[TBL] [Abstract][Full Text] [Related]
12. Serological profiling of the EBV immune response in Chronic Fatigue Syndrome using a peptide microarray.
Loebel M; Eckey M; Sotzny F; Hahn E; Bauer S; Grabowski P; Zerweck J; Holenya P; Hanitsch LG; Wittke K; Borchmann P; Rüffer JU; Hiepe F; Ruprecht K; Behrends U; Meindl C; Volk HD; Reimer U; Scheibenbogen C
PLoS One; 2017; 12(6):e0179124. PubMed ID: 28604802
[TBL] [Abstract][Full Text] [Related]
13. Reactivation of herpesvirus type 6 and IgA/IgM-mediated responses to activin-A underpin long COVID, including affective symptoms and chronic fatigue syndrome.
Vojdani A; Almulla AF; Zhou B; Al-Hakeim HK; Maes M
Acta Neuropsychiatr; 2024 Jun; 36(3):172-184. PubMed ID: 38571295
[TBL] [Abstract][Full Text] [Related]
14. Studies on the relationship between chronic fatigue syndrome and Epstein-Barr virus in Japan.
Kawai K; Kawai A
Intern Med; 1992 Mar; 31(3):313-8. PubMed ID: 1319246
[TBL] [Abstract][Full Text] [Related]
15. EBV/HHV-6A dUTPases contribute to myalgic encephalomyelitis/chronic fatigue syndrome pathophysiology by enhancing TFH cell differentiation and extrafollicular activities.
Cox BS; Alharshawi K; Mena-Palomo I; Lafuse WP; Ariza ME
JCI Insight; 2022 Jun; 7(11):. PubMed ID: 35482424
[TBL] [Abstract][Full Text] [Related]
16. Antibodies to Human Herpesviruses in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients.
Blomberg J; Rizwan M; Böhlin-Wiener A; Elfaitouri A; Julin P; Zachrisson O; Rosén A; Gottfries CG
Front Immunol; 2019; 10():1946. PubMed ID: 31475007
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus (EBV) and the chronic fatigue syndrome: normal virus load in blood and normal immunologic reactivity in the EBV regression assay.
Swanink CM; van der Meer JW; Vercoulen JH; Bleijenberg G; Fennis JF; Galama JM
Clin Infect Dis; 1995 May; 20(5):1390-2. PubMed ID: 7620030
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous measurement of antibodies to Epstein-Barr virus, human herpesvirus 6, herpes simplex virus types 1 and 2, and 14 enteroviruses in chronic fatigue syndrome: is there evidence of activation of a nonspecific polyclonal immune response?
Manian FA
Clin Infect Dis; 1994 Sep; 19(3):448-53. PubMed ID: 7811864
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus-encoded dUTPase modulates immune function and induces sickness behavior in mice.
Padgett DA; Hotchkiss AK; Pyter LM; Nelson RJ; Yang E; Yeh PE; Litsky M; Williams M; Glaser R
J Med Virol; 2004 Nov; 74(3):442-8. PubMed ID: 15368518
[TBL] [Abstract][Full Text] [Related]
20. Antibody responses to Epstein-Barr virus, human herpesvirus 6 and human herpesvirus 7 in patients with chronic fatigue syndrome.
Sairenji T; Yamanishi K; Tachibana Y; Bertoni G; Kurata T
Intervirology; 1995; 38(5):269-73. PubMed ID: 8724857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
